vidarabine has been researched along with Cell Transformation, Neoplastic in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmutz, JL; Trechot, P | 1 |
| Afrough, A; Hamdi, A; Hosing, CM; Lu, G; Muzzafar, T; Popat, UR; Qazilbash, MH | 1 |
| Benjamini, O; Burger, J; Estrov, Z; Ferrajoli, A; Jain, P; Kantarjian, H; Keating, M; Lerner, S; O'Brien, S; Qiao, W; Strom, SS; Trinh, L; Wang, X; Wierda, W | 1 |
| Bahlo, J; Cramer, P; Eichhorst, B; Engelke, A; Fink, AM; Fischer, K; Hallek, M; Kovacs, G; Langerbeins, P; Maurer, C; Müller, L; Pflug, N; Ritgen, M; Seiler, T; Stilgenbauer, S; von Tresckow, J; Wendtner, CM | 1 |
| Boubaya, M; Choquet, S; Delmer, A; Dupuis, J; Le Gouill, S; Leblond, V; Levy, V; Ouzegdouh, M; Pégourié-Bandelier, B; Souchet, L; Tamburini, J; Tournilhac, O; Vargaftig, J | 1 |
| Adamia, S; Ciccarelli, BT; Ghobrial, IM; Hatjiharissi, E; Hunter, ZR; Ioakimidis, L; Leleu, X; Manning, R; Moreau, AS; Patterson, CJ; Roccaro, A; Sacco, A; Soumerai, J; Treon, SP | 1 |
| Burchette, J; Foo, WC; Huang, Q; Hutchinson, CB; Sebastian, S; Wang, E | 1 |
| Rossi, D | 1 |
| Appelbaum, FR; Belch, A; Kolitz, JE; Larson, RA; Morrison, VA; Peterson, BL; Rai, KR; Solh, M; Tallman, MS | 1 |
| Andreeff, M; Cortes, JE; Faderl, S; Giles, FJ; Kantarjian, HM; Keating, MJ; O'Brien, SM; Tsimberidou, AM | 1 |
| Bellas, C; Catovsky, D; Matutes, E; Pocock, C; Santon, A; Shah, G; Thornton, PD; Wotherspoon, AC | 1 |
| Byrd, JC; Croce, CM; De Lay, MD; Edwards, RB; Grever, MR; Johnson, AJ; Lucas, DM; Muthusamy, N; Smith, LL | 1 |
| Algarotti, A; Bernasconi, P; Boni, M; Brusamolino, E; De Amici, M; Giardini, I; Lazzarino, M; Orlandi, E; Paulli, M; Perfetti, V; Tenore, AM; Vanelli, L; Zibellini, S | 1 |
| Abbondanzo, SL; Aguilera, NI; Byrd, JC; Diehl, LF; Lichy, JH; Shields, DJ | 1 |
| Craise, LM; George, KA; Mei, M; Yang, TC | 1 |
| Amir, G; Berrebi, A; Cohen, Y; Da'as, N; Libster, D; Polliack, A | 1 |
| Dostal, V; Fanta, D; Reiss-Gutfreund, RJ | 1 |
| Hassett, CM; Price, PJ; Skeen, PC | 1 |
| Azzam, EI; Feeley, M; Raaphorst, GP; Sargent, MD | 1 |
1 review(s) available for vidarabine and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
[Herpes simplex virus (hsv-1 and hsv-2) infection: its clinical and oncogenic properties (author's transl)].
Topics: Amantadine; Animals; Antibody Formation; Antigen-Antibody Complex; BCG Vaccine; Cell Transformation, Neoplastic; Complement C3; Cytarabine; DNA, Viral; Female; Ganglia; Genital Diseases, Female; Genital Diseases, Male; Haplorhini; Herpes Labialis; Herpes Simplex; Herpesvirus 4, Human; Humans; Idoxuridine; Immunity, Cellular; Levamisole; Male; Proflavine; Prostatic Neoplasms; Rabbits; Uterine Cervical Neoplasms; Vidarabine; Viral Vaccines | 1977 |
2 trial(s) available for vidarabine and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL.
Topics: Adult; Aged; Aged, 80 and over; Bendamustine Hydrochloride; Case-Control Studies; Cell Transformation, Neoplastic; Chlorambucil; Cyclophosphamide; Disease-Free Survival; Female; Germany; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasms, Second Primary; Registries; Risk Assessment; Risk Factors; Vidarabine | 2016 |
Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cisplatin; Cyclophosphamide; Cytarabine; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Middle Aged; Vidarabine | 2002 |
16 other study(ies) available for vidarabine and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
[Subcutaneous panniculitis-like T-cell lymphoma following treatment with rituximab and cyclophosphamide].
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cell Transformation, Neoplastic; Cyclophosphamide; Diagnosis, Differential; Gene Rearrangement, T-Lymphocyte; Humans; Immunophenotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, T-Cell, Cutaneous; Male; Mitomycin; Neoplasms, Second Primary; Panniculitis; Rituximab; Subcutaneous Tissue; T-Lymphocytes; Vidarabine | 2013 |
Donor cell-derived myelodysplastic syndrome with ring chromosome 7 after allogeneic hematopoietic stem cell transplant in 2 patients with lymphomas as primary disease.
Topics: Allografts; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Biomarkers, Tumor; Bone Marrow; Cell Transformation, Neoplastic; Chromosome Deletion; Chromosomes, Human, Pair 7; Cyclophosphamide; Disease Progression; ETS Translocation Variant 6 Protein; Female; Gene Deletion; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Living Donors; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Proto-Oncogene Proteins c-ets; Repressor Proteins; Ring Chromosomes; Rituximab; Transplantation Chimera; Vidarabine | 2014 |
Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cyclophosphamide; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Retrospective Studies; Risk Factors; Rituximab; Survival Rate; Vidarabine | 2015 |
Efficacy and long-term toxicity of the rituximab-fludarabine-cyclophosphamide combination therapy in Waldenstrom's macroglobulinemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cyclophosphamide; Female; Humans; Male; Middle Aged; Pancytopenia; Retrospective Studies; Rituximab; Survival Rate; Treatment Outcome; Vidarabine; Waldenstrom Macroglobulinemia | 2016 |
Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs.
Topics: Adult; Aged; Aged, 80 and over; Cell Transformation, Neoplastic; Chlorambucil; Cladribine; Female; Follow-Up Studies; Humans; Incidence; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Nucleosides; Retrospective Studies; Vidarabine; Waldenstrom Macroglobulinemia | 2009 |
Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative dis
Topics: Aged; Antineoplastic Agents; B-Lymphocytes; Cell Transformation, Neoplastic; Clone Cells; Epstein-Barr Virus Infections; Fatal Outcome; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large-Cell, Immunoblastic; Lymphoproliferative Disorders; Male; Neoplasms, Multiple Primary; Plasma Cells; Vidarabine | 2010 |
Richter syndrome and fludarabine: a controversial relationship.
Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Male; Vidarabine | 2013 |
The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011).
Topics: Adult; Aged; Antineoplastic Agents; Cell Transformation, Neoplastic; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Male; Middle Aged; Neoplasm Staging; Treatment Outcome; Vidarabine | 2013 |
Richter's transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Disease Progression; Female; Herpesvirus 4, Human; Humans; Kidney; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Nodes; Male; Middle Aged; Reed-Sternberg Cells; Treatment Outcome; Tumor Suppressor Protein p53; Vidarabine | 2005 |
Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia.
Topics: Animals; Antineoplastic Agents; CD5 Antigens; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mice; Mice, Transgenic; Neoplasm Proteins; Proto-Oncogene Proteins; Tumor Cells, Cultured; Vidarabine | 2006 |
Development of a Richter syndrome with a monoclonal component from a true B-cell chronic lymphocytic leukemia (B-CLL) treated with fludarabine.
Topics: Cell Transformation, Neoplastic; Female; Genes, Immunoglobulin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Vidarabine | 2007 |
Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD; Antigens, Viral; Antineoplastic Agents; CD4 Lymphocyte Count; Cell Transformation, Neoplastic; DNA Primers; Female; Herpesvirus 4, Human; Humans; In Situ Hybridization; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Polymerase Chain Reaction; RNA, Viral; Vidarabine; Viral Matrix Proteins | 1997 |
DNA damage and repair in oncogenic transformation by heavy ion radiation.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Transformed; Cell Survival; Cell Transformation, Neoplastic; Cosmic Radiation; Dimethyl Sulfoxide; DNA; DNA Damage; DNA Repair; DNA Restriction Enzymes; Dose-Response Relationship, Radiation; Embryo, Mammalian; Fibroblasts; Free Radical Scavengers; Gamma Rays; Ions; Linear Energy Transfer; Mice; Protons; Vidarabine; X-Rays | 1996 |
Large-cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine-rituximab-containing regimens: natural history- or therapy-related complication?
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Follow-Up Studies; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neoplasms, Second Primary; Rituximab; Time Factors; Vidarabine | 2002 |
9-beta-D-Arabinofuranosyladenine inhibition of chemically induced rat embryo cell transformation.
Topics: Cell Transformation, Neoplastic; Cells, Cultured; Drug Evaluation, Preclinical; Methylcholanthrene; Vidarabine | 1978 |
Inhibitors of repair of potentially lethal damage and DNA polymerases also influence the recovery of potentially neoplastic transforming damage in C3H10T-1/2 cells.
Topics: Animals; Aphidicolin; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Diterpenes; DNA Polymerase I; DNA Polymerase II; DNA Repair; Mice; Mice, Inbred C3H; Vidarabine | 1990 |